Astroglial cells represent a target for HIV infection in the central nervou
s system. In astrocytes, HIV infection is poorly productive, being characte
rized by a persistent state of viral latency. However, activation of the nu
clear factor NF-kappa B and its binding to HIV long terminal repeat (LTR) c
an induce HIV replication. Moreover, nitric oxide (NO) can affect NF-kappa
B activation in glial cells. Therefore, we hypothesize that NO may reduce H
IV replication in human astroglial cells by inhibiting HIV-1 LTR transcript
ional activity. In this respect, we show that NO donors reduce viral replic
ation in HIV-l-infected human astrocytoma T67 cells, taken as an astroglial
model, Furthermore, using transfected T67 cells, we demonstrate that NO do
nors inhibit HIV-1 LTR transcriptional activity. These results suggest that
the use of NO-releasing drugs may represent a potential, novel approach in
inhibiting HIV replication in the central nervous system. (C) 1999 Academi
c Press.